/content/dam/www/people-profile-photos/p/amanda-paulovich/amanda-paulovich-d.jpg
/content/dam/www/people-profile-photos/p/amanda-paulovich/provider-amanda-paulovich-directory-2x.jpg
Paulovich
Amanda Paulovich, MD, PhD

Amanda Paulovich, MD, PhD

  • Professor, Translational Science and Therapeutics Division, Fred Hutch
  • Member, Immunotherapy Integrated Research Center (IIRC), Fred Hutch
  • Aven Foundation Endowed Chair, Fred Hutch
  • Professor, Department of Medicine, Division of Hematology and Oncology, University of Washington School of Medicine
  • Associate Faculty Member, Molecular and Cellular Biology Program, University of Washington
206.667.1912
206.667.2277

Background

Dr. Amanda Paulovich is a leader in proteomics, the study of proteins — the cell’s workhorse molecules. Due to a lack of tools, proteomics has lagged behind the study of genes, which provide the blueprints for proteins. And just as a blueprint can’t tell you everything about a finished house, our genetic blueprint only reveals part of the biological picture. By developing powerful protein-measuring tools, Dr. Paulovich helps to fill in this picture and open the door to treatments tailored to individual cancer patients.

Her team has spearheaded the development of assays that use a technique called multiple reaction monitoring mass spectrometry, or MRM-MS, to detect and precisely measure the amount of a particular protein. This technology will help researchers combine detailed information about proteins with genetic data to learn, for instance, which genetic mutations drive a cancer’s development and suggest new therapeutic targets.

Director, Clinical Research Proteomics Platform, Brotman Baty Institute for Precision Medicine

Education

Fellowship, Medical Oncology, Dana Farber Cancer Institute, 2004

Postdoctoral Fellowship, Computational Biology, MIT-Whitehead Center for Genomic Research, 2003

Residency, Internal Medicine, Massachusetts General Hospital, 2000

MD, University of Washington, 1998

PhD, Genetics, University of Washington, 1996

BS, Biological Sciences, Carnegie Mellon University, 1988

"The idea behind personalized medicine is figuring out what's the ideal intervention for you, which will cut costs and improve our treatments — that's the ultimate goal."

— Dr. Amanda Paulovich

Find a Clinical Trial

Stories

All news
Big-picture approach helps identify experimental diagnostic to personalize ovarian cancer treatment Team uses large-scale proteogenomic changes to identify which patients should look beyond standard treatment options August 3, 2023
Omics made easier To see the big picture, just add ‘ome’ March 30, 2021
Scientists predict progress against COVID-19, cancer in 2021 After a challenging and deadly 2020, some hopeful predictions for the new year December 22, 2020